Author pages are created from data sourced from our academic publisher partnerships and public sources.
The economic burden of non-influenza-related viral respiratory tract infection in the United States.
- A. Fendrick, A. Monto, B. Nightengale, M. Sarnes
- Archives of internal medicine
- 24 February 2003
BACKGROUND Viral respiratory tract infection (VRTI) is the most common illness in humans. Despite the high incidence, the economic impact of non-influenza-related VRTI has not been rigorously… Expand
Acute respiratory illness in the community. Frequency of illness and the agents involved.
Investigations of respiratory illnesses and infections in Tecumseh, Michigan, USA, were carried out in two phases, together covering 11 years. During the second phase, there were 5363 person-years of… Expand
Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use
- A. Monto, J. Mckimm-Breschkin, +8 authors M. Zambon
- Biology, Medicine
- Antimicrobial Agents and Chemotherapy
- 1 July 2006
ABSTRACT Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) develops at a low level following drug treatment, and person-to-person transmission of resistant… Expand
Epidemiology of viral respiratory infections
- A. Monto
- The American Journal of Medicine
- 22 April 2002
Abstract Acute respiratory tract infections are the most common illnesses in all individuals, regardless of age or gender. Epidemiologic surveys and community-based studies conducted since the… Expand
Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial.
- A. Aiello, G. F. Murray, +6 authors A. Monto
- The Journal of infectious diseases
- 15 February 2010
BACKGROUND During the influenza A(H1N1) pandemic, antiviral prescribing was limited, vaccines were not available early, and the effectiveness of nonpharmaceutical interventions (NPIs) was uncertain.… Expand
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
BACKGROUND Despite widespread use, questions remain about the efficacy of oseltamivir in the treatment of influenza. We aimed to do an individual patient data meta-analysis for all clinical trials… Expand
Low sensitivity of rapid diagnostic test for influenza.
- T. Uyeki, R. Prasad, +8 authors A. Monto
- Clinical infectious diseases : an official…
- 1 May 2009
The QuickVue Influenza A+B Test (Quidel) was used to test nasal swab specimens obtained from persons with influenza-like illness in 3 different populations. Compared with reverse-transcriptase… Expand
Estimating household and community transmission parameters for influenza.
- I. Longini, J. Koopman, A. Monto, J. P. Fox
- Biology, Medicine
- American journal of epidemiology
- 1 May 1982
A maximum likelihood procedure is given for estimating household and community transmission parameters from observed influenza infection data. The estimator for the household transmission probability… Expand
Comparative efficacy of inactivated and live attenuated influenza vaccines.
- A. Monto, S. Ohmit, +6 authors J. C. Victor
- The New England journal of medicine
- 10 December 2009
BACKGROUND The efficacy of influenza vaccines may vary from year to year, depending on a variety of factors, and may differ for inactivated and live attenuated vaccines. METHODS We carried out a… Expand
Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses
ABSTRACT Neuraminidase inhibitors (NAIs) are antivirals designed to target conserved residues at the neuraminidase (NA) enzyme active site in influenza A and B viruses. The conserved residues that… Expand